Accuracy of Family History of Hemochromatosis or Iron Overload: The Hemochromatosis and Iron Overload Screening Study

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 8, 2008, Pages 934-938

  Acton, Ronald T ^a   Barton, James C ^b   Passmore, Leah V ^c   Adams, Paul C ^d   Mclaren, Gordon D ^e,f   Leiendecker Foster, Catherine ^g   Speechley, Mark R ^h   Harris, Emily L ⁱ   Castro, Oswaldo ^j   Reiss, Jacob A ^k   Snively, Beverly M ^c   Harrison, Barbara W ^j   Mclaren, Christine E ^f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b SOUTHERN IRON DISORDERS CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF WESTERN ONTARIO   (Canada)

ⁱ NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^j HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^k Kaiser Permanente Northwest ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HEART DISEASE; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; SCREENING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; GENOTYPE; HEART DISEASES; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; LIVER DISEASES; MALE; MEDICAL HISTORY TAKING; MEMBRANE PROTEINS; MIDDLE AGED; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 47949112557     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.04.003     Document Type: Article

References (30)

1. Edwards C.Q., Griffen L.M., Goldgar D., et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318 (1988) 1355-1362
2. Witte D.L., Crosby W.H., Edwards C.Q., et al. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 245 (1996) 139-200
3. Motulsky A.G., and Beutler E. Population screening in hereditary hemochromatosis. Annu Rev Public Health 21 (2000) 65-79
4. Barton J.C., McDonnell S.M., Adams P.C., et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 129 (1998) 932-939
5. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
6. Brown A.S., Gwinn M., Cogswell M.E., et al. Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997. Genet Med 3 (2001) 109-111
7. Acton R.T., Bamberg R., and Roseman J.M. Integration of genetic information into preventive care. In: Matzen R.N., and Lang R.S. (Eds). Clinical preventive medicine (1993), Mosby, St. Louis 765-783
8. Yoon P.W., Scheuner M.T., Peterson-Oehlke K.L., et al. Can family history be used as a tool for public health and preventive medicine?. Genet Med 4 (2002) 304-310
9. Adams P.C., Walker A.P., and Acton R.T. A primer for predicting risk of disease in HFE-linked hemochromatosis. Genet Test 5 (2001) 311-316
10. Assy N., and Adams P.C. Predictive value of family history in diagnosis of hereditary hemochromatosis. Dig Dis Sci 42 (1997) 1312-1315
11. Nelson R.L., Persky V., Davis F., et al. Risk of disease in siblings of patients with hereditary hemochromatosis. Digestion 64 (2001) 120-124
12. Harris EL, Acton RT, Snively BM, et al. Using family history of hemochromatosis or iron overload to aid targeted screening in a multiethnic, primary-care population: the Hemochromatosis and Iron Overload Screening (HEIRS) study. Poster #1194 presented at the annual meeting of The American Society of Human Genetics, October 25-29, 2005, Salt Lake City, UT. Available at: http://www.ashg.org/genetics/ashg05s/. Accessed June 6, 2008.
13. McLaren C.E., Barton J.C., Adams P.C., et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 325 (2003) 53-62
14. Acton R., Snively B., Barton J., et al. A genome-wide linkage scan for iron phenotype quantitative trait loci: the HEIRS Family Study. Clin Genet 71 (2007) 518-529
15. O'Connell J.R., and Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63 (1998) 259-266
16. McPeek M.S., and Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet 66 (2000) 1076-1094
17. Bamberg R., Acton R.T., Roseman J.M., et al. The effect of genetic risk information on compliance with preventive health behaviors. Health Educ 21 (1990) 226-232
18. Baptiste-Roberts K., Gary T.L., Beckles G.L., et al. Family history of diabetes, awareness of risk factors, and health behaviors among African Americans. Am J Public Health 97 (2007) 907-912
19. Yoon P.W., Scheuner M.T., and Khoury M.J. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 24 (2003) 128-135
20. Bradley L.A., Haddow J.E., and Palomaki G.E. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen 3 (1996) 171-177
21. Niederau C., Fischer R., Sonnenberg A., et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 313 (1985) 1256-1262
22. Milman N., Pedersen P., Steig T., et al. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80 (2001) 737-744
23. Hicken B.L., Tucker D.C., and Barton J.C. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis. Am J Gastroenterol 98 (2003) 2072-2077
24. Hunt S.C., Williams R.R., and Barlow G.K. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 39 (1986) 809-821
25. Acton RT G.R., Roseman J.M., Perkins L.L., et al. Use of self-administered family history of disease instruments to predict individuals at risk for cardiovascular diseases, hypertension and diabetes. Am J Hum Genet 45 (1989) A275
26. Bensen J.T., Liese A.D., Rushing J.T., et al. Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS). Genet Epidemiol 17 (1999) 141-150
27. Bassett M., Dunn C., Battese K., et al. Acceptance of neonatal genetic screening for hereditary hemochromatosis by informed parents. Genet Test 5 (2001) 317-320
28. Gason A., Aitken M., Metcalfe S., et al. Genetic susceptibility screening in schools: attitudes of the school community towards hereditary haemochromatosis. Clin Genet 67 (2005) 166-174
29. Acton R.T., Barton J.C., Casebeer L., et al. Survey of physician knowledge about hemochromatosis. Genet Med 4 (2002) 136-141
30. McDonnell S.M., Preston B.L., Jewell S.A., et al. A survey of 2,851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 106 (1999) 619-624